Head-to-Head

ABBVIE INC. vs. Bristol-Myers Squibb Co.

ABBV

ABBVIE INC.

$264.47 +0.17%

VS BMY

Bristol-Myers Squibb Co.

$62.84 -1.19%

Bristol-Myers Squibb Co. (BMY) comes out ahead, leading on 8 of 11 compared factors.

Size & Scale

ABBVBMY
Market Cap $466.55 billion $129.92 billion
Revenue (TTM) $64.39 billion $49.19 billion
Net Income (TTM) $6.32 billion $9.27 billion

ABBV leads on 2 of 3 size & scale factors.

Valuation

ABBVBMY
P/E Ratio 74.71 13.84
Price / Book -79.24 5.82
Price / Sales 7.25 2.64

BMY leads on 2 of 3 valuation factors.

Profitability

ABBVBMY
Net Margin 9.81% 18.85%
Return on Equity -107.29% 41.55%

BMY leads on 2 of 2 profitability factors.

Dividend

ABBVBMY
Dividend Yield 2.62% 4.01%
Payout Ratio 195.48 55.51

BMY leads on 2 of 2 dividend factors.

Risk & Sentiment

ABBVBMY
Short Interest 0.85% 0.39%

BMY leads on 1 of 1 risk & sentiment factors.

Dig deeper: ABBV overview, ABBV financials, BMY overview, BMY financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.